J and J Snack Foods Newswire

Comprehensive Real-Time News Feed for J and J Snack Foods.

Results 1 - 20 of 1,044 in J and J Snack Foods

  1. J&J to acquire VC-backed Alios BioPharma for $1.75 blnRead the original story w/Photo

    6 hrs ago | PE Hub

    Last April, Alios BioPharma raised $41 million in Series B funding. Investors included Novo Ventures, SR One, Roche Venture Fund and Novartis Ventures . And, in February 2009, Alios received $8.4 million in Series A funding. Backers in that round were Novo, Novartis and Roche.

    Comment?

  2. Endo Said to Pay More Than $400 Million in Vaginal-Mesh PactRead the original story

    10 hrs ago | The Washington Post

    Endo International Plc agreed to pay more than $400 million to resolve lawsuits alleging its vaginal- mesh implants eroded in some women and left them in pain, people familiar with the settlement said. Endo, which rose almost two percent today, said it settled "substantially all" the remaining U.S. suits against its American Medical Systems Holdings unit over the Perigee, Apogee and Elevate mesh implants, Chief Executive Officer Rajiv De Silva said yesterday in a statement.

    Comment?

  3. J&J to buy antiviral specialist AliosRead the original story

    17 hrs ago | Chemistry World

    Johnson and Johnson has agreed to buy antiviral specialist Alios BioPharma for $1.75 billion . The deal gives J&J's Janssen subsidiary access to two compounds currently in Phase II trials, plus a pipeline of related compounds.

    Comment?

  4. J&J purchase of Alios an incremental negative for Achillion, says UBSRead the original story

    Wednesday Sep 17 | Theflyonthewall.com

    Treasury rules put downside risk on AbbVie, Shire deal, says Jefferies Jefferies believes Treasury's new inversion rules create downside risk to AbbVie's acquisition of Shire from a value perspective. The firm thinks "many reasons" still exist to acquire Shire, but not necessarily at the currently agreed price.

    Comment?

  5. Endo Said to Pay $400 Million Plus in Vaginal-Mesh AccordRead the original story

    18 hrs ago | Bloomberg

    Endo International Plc agreed to pay more than $400 million to resolve lawsuits alleging its vaginal-mesh implants eroded in some women and left them in pain, people familiar with the settlement said. Endo settled "substantially all" the remaining U.S. suits against its American Medical Systems Holdings unit over the Perigee, Apogee and Elevate mesh implants, Chief Executive Officer Rajiv De Silva said yesterday in a statement.

    Comment?

  6. J&J's Alios Buyout Bodes Interesting Times F...Read the original story w/Photo

    Tuesday | Investor's Business Daily

    The drama continued for big biotech Gilead Sciences Tuesday, as Johnson & Johnson moved into its viral-disease turf on two fronts with an acquisition. disclosed that it's buying privately held Alios BioPharma for $1.75 billion in cash.

    Comment?

  7. J&J Buying Alios, Going Up Against GileadRead the original story w/Photo

    Tuesday | Investor's Business Daily

    The drama continued for big biotech Gilead Sciences Tuesday, as Johnson & Johnson moved into its viral-disease turf on two fronts with an acquisition. disclosed that it's buying privately held Alios BioPharma for $1.75 billion in cash.

    Comment?

  8. J&J purchase will help it compete with GileadRead the original story w/Photo

    Tuesday | MarketWatch

    When a conglomerate the size of Johnson & Johnson spends $1.75 billion to buy a small-ish biotech company, the deal will have little immediate impact on the bottom line. buyout of privately held Alios BioPharma may pay bigger dividends down the road, and help it compete with flourishing biotech Gilead Sciences Inc. Yee said in a note to clients Tuesday that J&J's plans to buy Alios are centered around a respiratory virus treatment that already has shown promise.

    Comment?

  9. J&J to Acquire Alios BioPharma for $1.75 BillionRead the original story

    Tuesday | WRKO-AM Brighton

    Johnson & Johnson agreed to pay $1.75 billion to acquire privately held Alios BioPharma Inc., a developer of experimental treatments for viral diseases including hepatitis C.

    Comment?

  10. HurelA Corporation Completes Investment from Johnston Associates, Inc.Read the original story

    Wednesday Sep 24 | B3C

    North Brunswick, NJ, USA, September 24, 2014 / B3C newswire / - Hurel Corporation , a world-leading provider of in vitro liver models and microfluidic assay platforms that improve the predictive reliability of pre-clinical drug development, today announced that Johnston Associates, Inc. of Princeton, New Jersey has become a participating investor in the Company's Series A-3 Preferred Stock financing. Hurel's lead private equity investor, Spring Mountain Capital, LP, of New York, led the A-3 round.

    Comment?

  11. J&J deal for Alios sets valuation benchmark for Novavax, says Piper JaffrayRead the original story

    Tuesday Sep 16 | Theflyonthewall.com

    Achillion sinks after Johnson & Johnson buys competitor The shares of Achillion , which has developed a treatment for hepatitis C based on a nucleotide and has been viewed as a potential takeover target by analysts previously, are falling after Johnson & Johnson announced this morning that it had agreed to acquire privately held Alios Biopharma. Alios has developed a number of nucleotide-based hepatitis C treatments, as well as an orally administered antiviral therapy currently in Phase 2 studies for the treatment of infants with respiratory syncytial virus.

    Comment?

  12. J&J goes 'nuc'lear with $1.75 billion buyout of Alios BioPharmaRead the original story w/Photo

    Tuesday | Business Journal

    Johnson & Johnson will buy South San Francisco's Alios BioPharma Inc. in a $1.75 billion cash deal that will boost the big pharmaceutical company's profile in hepatitis C and other virus fighters. Partner Vertex Pharmaceuticals Inc. has an Alios-developed hepatitis C drug, called ALS-2200 or VS-135, in mid-stage human studies, but Alios' power for J&J may rest deeper in the company's portfolio.

    Comment?

  13. eBay Separates PayPal, J&J to Acquire Alios BioPharma for $1.8 BRead the original story

    Tuesday | Ticker

    Johnson & Johnson plans to acquire privately held Alios BioPharma for $1.8 billion. Walgreen net swung to a loss.

    Comment?

  14. J&J Gains Viral Therapies in $1.75 Billion Alios AcquisitionRead the original story

    Tuesday | Bloomberg

    Johnson & Johnson , the biggest maker of consumer health products, said it will acquire Alios BioPharma Inc., a developer of viral disease therapies. J&J will pay $1.75 billion in cash for closely held Alios, according to a statement today.

    Comment?

  15. J&J buying Alios for $1.75BRead the original story

    Tuesday | Bioscience Technology

    The deal includes Alios' portfolio of potential therapeutics for viral infections including compound AL-8176, an orally administered antiviral therapy currently in Phase 2 studies for the treatment of infants with respiratory syncytial virus. RSV typically causes only mild, cold-like symptoms in most children.

    Comment?

  16. J&J plans $1.75bn Alios acquisitionRead the original story w/Photo

    Tuesday | RTE.ie

    Johnson & Johnson plans to acquire Alios BioPharma, a private company specializing in treatments for viral diseases, for $1.75 billion, the companies have announced. The all-cash deal will include an Alios medication still under trial for treating infants with respiratory syncytial virus, a common ailment in young children.

    Comment?

  17. Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, NovavaxRead the original story w/Photo

    Tuesday | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  18. Deals of the Day: EBay Spins Off PayPal, Working the Phones at PimcoRead the original story w/Photo

    Tuesday | WSJ Media and Advertising

    Deals of the Day is your one-stop-shop for the morning's biggest news from the finance beat, including M&A, IPOs, banks, hedge funds and private equity. Here's what's happening today: EBay to spin off PayPal.

    Comment?

  19. J&J to Acquire Alios BioPharmaRead the original story w/Photo

    Tuesday | Contract Pharma Breaking News

    Johnson & Johnson has entered a definitive agreement to acquire Alios BioPharma, Inc. , a clinical stage biopharma company focused on therapies for viral diseases, for approximately $1.75 billion in cash. Alios' lead candidate AL-8176 is an orally administered antiviral therapy currently in Phase II development for the treatment of infants with respiratory syncytial virus .

    Comment?

  20. J&J could have considered Novavax, Achillion instead of Alios, TheStreet saysRead the original story

    Tuesday Sep 16 | Theflyonthewall.com

    Sachs Associates to hold a conference 14th Annual Biotech in Europe Forum for Global Partnering and Investment to be held in Basel, Switzerland on September 30-October 1. Novavax H7N9 vaccine candidate delivers positive Phase 1/2 clinical data Novavax announced positive top-line data from a Phase 1/2 clinical trial of its H7N9 Avian Influenza VLP Vaccine Candidate, or H7N9 VLP, with proprietary adjuvant Matrix-M. This trial was conducted under the company's contract with HHS-BARDA for the development of VLPs to address influenza strains with pandemic potential.

    Comment?